What is the 13F Pro Quality Score for NAII?

13F Pro ranks NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) on the 13F Pro Quality Score, a 0–100 composite of 32 fundamental signals including return on invested capital, free cash flow consistency, balance-sheet strength, earnings quality, growth durability, and valuation discipline. The score refreshes after each 10-K and 10-Q filing on SEC EDGAR. View NAII's current score at https://13fpro.ai/research/NAII (free sign-up required for the full ranking).

Where does 13F Pro source NAII data?

All NATURAL ALTERNATIVES INTERNATIONAL INC fundamentals and ownership data come directly from SEC EDGAR. NATURAL ALTERNATIVES INTERNATIONAL INC files with the SEC under CIK 787253. 13F Pro ingests XBRL financial facts from 10-K and 10-Q filings, Form 13F-HR institutional holdings, and Form 4 insider transactions, with no third-party rewrites or estimates.

What sector is NAII in?

NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) is classified in the Healthcare sector. 13F Pro publishes sector-level fund flow analysis and quality leaders at https://13fpro.ai/research/sector/healthcare.

How often is NAII research updated on 13F Pro?

NAII's fundamentals refresh within hours of each new 10-K or 10-Q filing on SEC EDGAR. Institutional ownership updates after each quarterly 13F filing window. Insider transactions update after each Form 4 filing. The 13F Pro Quality Score recalculates after every fundamentals refresh.

NATURAL ALTERNATIVES INTERNATIONAL INC(NAII)Stock Analysis

AI analysis on 2,800+ stocks →Deep AI analysis on 2,800+ stocks →

Healthcare →Nasdaq

Institutional-grade research for retail investors

SEC EDGAR: CIK 787253 NAII stock profile & AI dashboard →

13F Pro Quality Score

Not in ranked universe

Limited institutional coverage

Quality rankings require at least 50 unique 13-F institutional holders to ensure peer comparisons are meaningful. Only 24 institutional filers currently hold this stock.

Financial data, filings, and institutional holdings below are still tracked in full — only the proprietary quality composite is unavailable for this name.

NAII Stock Analysis & AI Quality Score

AI stock analysis and institutional research for NATURAL ALTERNATIVES INTERNATIONAL INC (NAII), a Healthcare sector company. NAII is not currently included in 13F Pro's AI-ranked quality universe — quality rankings require at least 50 unique 13-f institutional holders to ensure peer comparisons are meaningful. only 24 institutional filers currently hold this stock. Based on the latest XBRL financial filings (Q3 2026), NATURAL ALTERNATIVES INTERNATIONAL INC reports quarterly revenue of $35.5M, net income of $-4.3M, free cash flow of $1.4M. Top institutional holders of NAII by reported 13-F value include CALDWELL SUTTER CAPITAL,, DIMENSIONAL FUND ADVISORS, Mink Brook Asset Management, based on the most recent SEC filings. NAII trades on the Nasdaq exchange and files with the SEC under CIK 787253. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate NAII daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for NATURAL ALTERNATIVES INTERNATIONAL INC directly from SEC EDGAR.

Revenue

Q3 2026

$35.5M

Net Income

Q3 2026

$-4.3M

Free Cash Flow

Q3 2026

$1.4M

Revenue & Net Income

Earnings Per Share

Key Financials Over Time

Export Financial Table · Pro+

Revenue

+14.1% YoY

$129.9MFY 2025

FY22 $171.0MFY23 $154.0MFY24 $113.8MFY25 $129.9M

Net Income

-88.1% YoY

$-13.6MFY 2025

FY22 $10.7MFY23 $2.5MFY24 $-7.2MFY25 $-13.6M

Operating Income

-1.5% YoY

$-8.7MFY 2025

FY22 $13.7MFY23 $4.7MFY24 $-8.5MFY25 $-8.7M

EPS (Diluted)

-85.4% YoY

$-2.28FY 2025

FY22 $1.74FY23 $0.43FY24 $-1.23FY25 $-2.28

Total Assets

-6.4% YoY

$151.9MFY 2025

FY22 $146.0MFY23 $134.2MFY24 $162.3MFY25 $151.9M

Op. Cash Flow

+496.3% YoY

$5.9MFY 2025

FY22 $11.9MFY23 $7.0MFY24 $-1.5MFY25 $5.9M

Metric	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Revenue	$129.9M +14.1%	$113.8M -26.1%	$154.0M -9.9%	$171.0M -4.2%	$178.5M +50.2%	$118.9M
Net Income	$-13.6M -88.1%	$-7.2M -386.2%	$2.5M -76.5%	$10.7M -0.5%	$10.8M +754.6%	$-1.6M
Operating Income	$-8.7M -1.5%	$-8.5M -281.1%	$4.7M -65.5%	$13.7M +0.1%	$13.7M +1006.0%	$-1.5M
EPS (Diluted)	$-2.28 -85.4%	$-1.23 -386.0%	$0.43 -75.3%	$1.74 +3.0%	$1.69 +776.0%	$-0.25
Total Assets	$151.9M -6.4%	$162.3M +21.0%	$134.2M -8.1%	$146.0M +21.4%	$120.3M +0.1%	$120.2M
Operating Cash Flow	$5.9M +496.3%	$-1.5M -121.3%	$7.0M -40.8%	$11.9M -43.0%	$20.8M +463.7%	$3.7M

AI Insight: NAII Financial Trends

NAII remains unprofitable across eight consecutive quarters despite modest revenue stabilization; equity erosion continues.

• Revenue stabilized around $34–$35M in recent quarters after Q3 2025 peak of $38M, but no profitable quarter achieved since Q2 2024.

• Operating cash flow erratic: swung from +$6M in Q1 2025 to −$6M in Q4 2025 to +$3M in Q1 2026, signaling operational instability.

• Shareholder equity declined 24% from $83M (Q2 2024) to $63M (Q1 2026) due to cumulative net losses.

⚠ Net loss widened to −$7M in Q2 2025 before narrowing to −$0M in Q3 2025, then deteriorated again; path to profitability unclear.

⚠ Operating margin remains negative every quarter; Q1 2026 operating loss of −$4M on flat $35M revenue suggests cost structure unaligned with sales.

AI Insight: NAII Ratio Trends

NAII swung to profitability in Q3 2025 but deteriorated sharply in Q4 2025 and Q1 2026, with operating margin now at −11.3% and ROIC at −25.4%.

• Operating margin briefly turned positive at 0.8% in Q3 2025, but collapsed to −11.3% by Q1 2026, the worst quarter in the dataset.

• Net profit margin deteriorated from −0.8% in Q3 2025 to −12.2% in Q1 2026, signaling sustained operational losses.

• ROIC swung from +1.7% in Q3 2025 to −25.4% in Q1 2026, destroying shareholder value at an accelerating rate.

⚠ Q2 2025 showed extreme distress: NPM crashed to −21.3%, ROE to −42.2%, ROA to −19.0%. Investigate whether Q3 rebound was temporary or structural.

⚠ TTM metrics remain deeply negative across all profitability and return measures; company has not generated positive earnings in trailing twelve months.

Get alerted when NAII's score changes

Free account: watchlist tracking, the daily AI brief, and the AI screener.

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Available Research

13F Pro tracks comprehensive data for NATURAL ALTERNATIVES INTERNATIONAL INC including:

SEC EDGAR filings (10-K, 10-Q, 8-K)

XBRL financial facts (revenue, EPS, margins)

Insider transactions (Form 4)

Institutional 13F holdings

Quality rankings (32 signals)

AI analyst debates & daily meetings

Historical financial trends

Peer comparison & sector analysis

Top Institutional Holders of NAII

CALDWELL SUTTER CAPITAL, INC.
$1.3M498,792 sh
DIMENSIONAL FUND ADVISORS LP
$933.0K354,739 sh
Mink Brook Asset Management LLC
$772.5K293,709 sh
RENAISSANCE TECHNOLOGIES LLC
$766.3K291,356 sh
MORGAN STANLEY
$705.5K268,250 sh
VANGUARD CAPITAL MANAGEMENT LLC
$554.6K210,880 sh
BRIDGEWAY CAPITAL MANAGEMENT, LLC
$198.1K75,316 sh
GEODE CAPITAL MANAGEMENT, LLC
$137.9K52,405 sh
CITADEL ADVISORS LLC
$115.0K43,708 sh
VANGUARD FIDUCIARY TRUST CO
$71.3K27,095 sh

Fund	Value	Shares
CALDWELL SUTTER CAPITAL, INC.	$1.3M	498,792
DIMENSIONAL FUND ADVISORS LP	$933.0K	354,739
Mink Brook Asset Management LLC	$772.5K	293,709
RENAISSANCE TECHNOLOGIES LLC	$766.3K	291,356
MORGAN STANLEY	$705.5K	268,250
VANGUARD CAPITAL MANAGEMENT LLC	$554.6K	210,880
BRIDGEWAY CAPITAL MANAGEMENT, LLC	$198.1K	75,316
GEODE CAPITAL MANAGEMENT, LLC	$137.9K	52,405
CITADEL ADVISORS LLC	$115.0K	43,708
VANGUARD FIDUCIARY TRUST CO	$71.3K	27,095

More Healthcare Companies

View all Healthcare →

AAPG

ASCENTAGE PHARMA GROUP INTERNATIONAL

AARD

Aardvark Therapeutics, Inc.

ABBV

AbbVie Inc.

ABCL

AbCellera Biologics Inc.

ABEO

ABEONA THERAPEUTICS INC.

ABOS

Acumen Pharmaceuticals, Inc.

ABPWW

Abpro Holdings, Inc.

ABSI

Absci Corp

Put NAII on your watchlist

Track score changes the day NATURAL ALTERNATIVES INTERNATIONAL INC files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.

View Pricing

Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Popular Research

AAPL

Apple

MSFT

Microsoft

NVDA

NVIDIA

GOOG

Alphabet

AMZN

Amazon

Is NAII a good stock to buy?

13F Pro's AI-powered analysis of NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Healthcare sector (listed on Nasdaq). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for NAII are available on the NAII stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing.

Which hedge funds own NAII?

Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling NAII. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of NATURAL ALTERNATIVES INTERNATIONAL INC's investment landscape.